Iontophoresis Transdermal Device Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current iontophoresis systems are limited by their complexity, lack of disposability, reliance on external power sources, and inefficiencies in drug delivery, leading to prolonged treatment times and patient immobility.

Innovation Solution

A combinational iontophoretic transdermal device that integrates traditional and low-voltage iontophoresis systems, featuring a multi-functional electrode patch with embedded or connectable power sources, allowing for skin conductivity enhancement followed by low-voltage iontophoresis, reducing treatment time and enhancing drug delivery efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional iontophoresis systems are used, then drug delivery function is provided, but treatment time is prolonged and patient mobility is restricted

Engineering Contradiction:
Improvetreatment efficiencyVSAvoidtreatment time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The system is divided into two independent modules: a reusable electronic dose controller and a disposable iontophoretic patch. This segmentation allows the patch to be pre-prepared and applied to the patient, enabling treatment to continue uninterrupted while the controller is removed for mobility, thus reducing overall treatment time and improving efficiency.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The iontophoretic patch is pre-assembled with electrodes, drug reservoirs, and adhesive layers before patient application. This preliminary preparation eliminates setup time during treatment and allows the patient to receive immediate therapy upon application, reducing total treatment time.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If traditional iontophoresis systems are used, then drug delivery is achieved, but device complexity increases

Engineering Contradiction:
Improvedrug delivery efficiencyVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The complex electronic dose control circuitry is extracted from the disposable patch and placed in a separate reusable controller. This extraction simplifies the patch design to basic electrochemical components, making it easier to manufacture and dispose, while the complex control functions are maintained in the durable controller.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The reusable electronic dose controller is designed to work with multiple different disposable patches for various drugs and treatment protocols. This multi-functionality reduces the need for multiple specialized devices, simplifying the overall system while maintaining high drug delivery efficiency through precise electronic control.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If single-use disposable patches are implemented, then safety and hygiene are improved, but manufacturing cost increases

Engineering Contradiction:
Improvepatient safetyVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The system separates the disposable single-use patch from the reusable controller. The patch contains only simple, low-cost components (electrodes, adhesive, drug reservoir) that are inexpensive to manufacture in large volumes, while the expensive electronic components are reused across multiple patients through the durable controller.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patch is designed as a simple, inexpensive, single-use component that can be mass-produced at low cost using basic manufacturing processes. Its simplicity (without complex electronics) makes it economically viable as a disposable item, ensuring patient safety through elimination of cross-contamination while controlling manufacturing costs.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Ease of operation

If on-board power sources are integrated into the patch, then independence from external power is achieved, but patch size and weight increase

Engineering Contradiction:
Improvedevice independenceVSAvoidpatch weight
Core Design Contradiction:
Ease of operationVSWeight of moving object

Solution Approach 1:

The power source function is extracted from the disposable patch and placed in the reusable controller. This extraction allows the patch to remain extremely lightweight and thin, while the controller houses the batteries and power management circuitry, providing independent power supply without burdening the patient with heavy patch components.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device significantly reduces treatment time, normalizes skin conductivity, and allows patients to be mobile during therapy, improving treatment efficiency and convenience while maintaining safety and effectiveness.

Implementation Method 1

Iontophoresis drug delivery systems have been commercially available in hospitals and clinics

Methodology Applied
Scientific EffectIontophoresis: Iontophoresis

Implementation Method 2

skin conductivity enhancement followed by low voltage iontophoresis

Methodology Applied
Scientific EffectElectrical conduction: Conduction (electrical)

Implementation Method 3

independent on-board power source

Methodology Applied
Scientific EffectBattery: Battery (electricity)

Data Source

PatentUS7996077B2Iontophoresis apparatus and method
Publication Date: 2011.08.09 ENCORE MEDICAL ASSET CORP
  • US7996077B2 patent drawing
  • US7996077B2 patent drawing
  • US7996077B2 patent drawing

AI summary

An iontophoresis apparatus and method is disclosed that is suited to deliver a plurality of treatment methods such as, but not limited to, body site conductivity enhancement followed by low voltage iontophoresis.